Metastatic Castration-Resistant Prostate Cancer Patients Recruiting Phase 2 Trials for Prednisolone (DB00860)

IndicationStatusPhase
DBCOND0113356 (Metastatic Castration-Resistant Prostate Cancer Patients)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03643107Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRPĀ®)Treatment